Despite bushfires, Bronwyn raises awareness and funds on NET Cancer Day

nAfter a diagnosis of Neuroendocrine cancer “by chance”, Bronwyn Wallace set about making it her mission to raise awareness and funds for the Unicorn Foundation.

BW11

“In October 2018, Bronwyn and her partner Paul’s lives changed forever when Bronwyn went to hospital with a superbug. A “very deligient” registrar in emergency ordered a scan which picked up, by chance, a mass in her intestine.

After numerous tests and surgeries, Brownwyn was diagnosed with NET in her terminal ileum (a part of the intestine). It had also spread to her lymph nodes.

Bronwyn has found immeasurable support from the Unicorn Foundation, and is making it her mission to help raise awareness on the cancer, and funds for the Foundation, which only has one NET nurse for Australia. 

“If I can just raise one per cent awareness for NETs, then it’s made a difference,” she said.” – Wingham Chronicle November 5.

On November 10, Bronwyn hosted a High Tea at Sass@Bowers, as part of World NET Cancer Day. Despite nearly having to cancel due to the devastating bushfires in the town, Bronwyn pushed on and the sold-out event went on to raise close to $2,000. To show our appreciation for the local community the Unicorn Foundation split the proceeds with the local community to support them through this devastating time.

BW9

Thank you to the Taree community for their support for Bronwyn and all her passion and hard work, and to all the donors. What an incredible reflection of the Australian spirit.

BW3

BW8

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

Neuroendocrine Cancer Day 2025

Racing for a Cure 2025

Celebrating Shane Kent’s Arch2Arc Journey and Fundraising

Sharon Rickard Completes Run Larapinta 2025!

Walk, run, or ride this March4NETs!

For its third year, March4NETs will run throughout March 2026.

Get involved and support the 31,000 Australians living with neuroendocrine cancer.